Healthstream (HSTM) Common Equity (2010 - 2026)

Healthstream (HSTM) has reported Common Equity for 17 consecutive years, with $356.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity rose 1.72% year-over-year to $356.6 million in Q2 2026; TTM through Jun 2026 was $356.6 million, a 1.72% increase from a year earlier, with the FY2025 full-year figure at $354.0 million, down 1.48% from the prior year.
• Common Equity was $356.6 million for Q2 2026 at Healthstream, up from $352.0 million in the prior quarter.
• Over five years, Common Equity peaked at $362.8 million in Q1 2025 and troughed at $322.6 million in Q1 2022.
• A 5-year average of $344.9 million and a median of $347.0 million in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity fell 4.23% in 2022 and gained 5.46% in 2024, its largest moves.
• Over 5 years, Common Equity stood at $334.1 million in 2022, then climbed by 2.0% to $340.8 million in 2023, then grew by 5.46% to $359.4 million in 2024, then fell by 1.48% to $354.0 million in 2025, then climbed by 0.73% to $356.6 million in 2026.
• The last three Common Equity figures came in at $356.6 million (Q2 2026), $352.0 million (Q1 2026), and $354.0 million (Q4 2025), per Business Quant data.